Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC)

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Drake, Charles G, Quinn, David, Dreicer, Robert, Antonarakis, Emmanuel, Shore, Neal, Corman, John, Concepcion, Raoul, Pieczonka, Christopher, Campogan, Dwayne, Fan, Li-Qun, Chang, Nancy, Sheikh, Nadeem, Petrylak, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Poster Presentation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4645289/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P145
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados